U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. FIBRYGA
  1. Approved Blood Products

FIBRYGA

STN# 125612
Proper Name: Fibrinogen (Human)
Tradename: FIBRYGA
Manufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.
Indication:

FIBRYGA is a human fibrinogen concentrate indicated for:

  • Fibrinogen supplementation in bleeding patients with acquired fibrinogen deficiency
  • Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia .
  • FIBRYGA is not indicated for dysfibrinogenemia

Product Information

Supporting Documents

Back to Top